3

PRIMARY DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: January 13, 2014
Period of Report: January 6, 2014
Accession Number: 0001250853-14-000014

View Document ↗ View on SEC.gov ↗